Deutsche Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-265,681
| Closed | -$18.1M | – | 4162 |
|
|
2022
Q3 | $18.1M | Buy |
265,681
+56,371
| +27% | +$3.11M | 0.01% | 787 |
|
|
2022
Q2 | $6.69M | Buy |
209,310
+26,906
| +15% | +$788K | ﹤0.01% | 1167 |
|
|
2022
Q1 | $6.32M | Sell |
182,404
-124,304
| -41% | -$3.72M | ﹤0.01% | 1297 |
|
|
2021
Q4 | $8.98M | Sell |
306,708
-18,659
| -6% | -$578K | ﹤0.01% | 1153 |
|
|
2021
Q3 | $8.29M | Sell |
325,367
-55,637
| -15% | -$1.64M | ﹤0.01% | 1243 |
|
|
2021
Q2 | $13.3M | Buy |
381,004
+59,849
| +19% | +$2.34M | 0.01% | 1058 |
|
|
2021
Q1 | $13.1M | Buy |
321,155
+59,894
| +23% | +$2.75M | 0.01% | 1069 |
|
|
2020
Q4 | $11.3M | Buy |
261,261
+91,151
| +54% | +$4.49M | 0.01% | 987 |
|
|
2020
Q3 | $9.38M | Buy |
170,110
+64,074
| +60% | +$4.07M | 0.01% | 983 |
|
|
2020
Q2 | $6.69M | Buy |
106,036
+11,707
| +12% | +$803K | 0.01% | 1156 |
|
|
2020
Q1 | $4.82M | Sell |
94,329
-4,375
| -4% | -$293K | ﹤0.01% | 1268 |
|
|
2019
Q4 | $7.84M | Buy |
98,704
+71,519
| +263% | +$4.24M | 0.01% | 1217 |
|
|
2019
Q3 | $1.32M | Sell |
27,185
-37,008
| -58% | -$1.93M | ﹤0.01% | 2154 |
|
|
2019
Q2 | $3.38M | Buy |
64,193
+44,962
| +234% | +$2.58M | ﹤0.01% | 2042 |
|
|
2019
Q1 | $1.02M | Sell |
19,231
-54,376
| -74% | -$2.67M | ﹤0.01% | 2980 |
|
|
2018
Q4 | $3.02M | Sell |
73,607
-162,417
| -69% | -$6.09M | ﹤0.01% | 2128 |
|
|
2018
Q3 | $8.97M | Buy |
236,024
+99,764
| +73% | +$4.42M | ﹤0.01% | 1732 |
|
|
2018
Q2 | $6.16M | Sell |
136,260
-538,898
| -80% | -$24.5M | ﹤0.01% | 2145 |
|
|
2018
Q1 | $32.6M | Buy |
675,158
+539,432
| +397% | +$30.1M | 0.02% | 835 |
|
|
2017
Q4 | $5.34M | Sell |
135,726
-342,103
| -72% | -$12.8M | ﹤0.01% | 1977 |
|
|
2017
Q3 | $14.8M | Buy |
477,829
+193,561
| +68% | +$5.44M | 0.01% | 1207 |
|
|
2017
Q2 | $7.77M | Buy |
284,268
+208,356
| +274% | +$6.2M | 0.01% | 1592 |
|
|
2017
Q1 | $2.79M | Buy |
75,912
+39,361
| +108% | +$991K | ﹤0.01% | 2039 |
|
|
2016
Q4 | $525K | Sell |
36,551
-39,766
| -52% | -$699K | ﹤0.01% | 3155 |
|
|
2016
Q3 | $1.76M | Buy |
76,317
+49,668
| +186% | +$947K | ﹤0.01% | 2442 |
|
|
2016
Q2 | $440K | Buy |
26,649
+21,106
| +381% | +$426K | ﹤0.01% | 3362 |
|
|
2016
Q1 | $87K | Sell |
5,543
-3,773
| -41% | -$67K | ﹤0.01% | 4083 |
|
|
2015
Q4 | $300K | Buy |
9,316
+7,410
| +389% | +$321K | ﹤0.01% | 3519 |
|
|
2015
Q3 | $80K | Buy |
+1,906
| New | +$89.9K | ﹤0.01% | 4201 |
|
Other funds holding GBT
Deutsche Bank's GBT Position: Q4 2022 in Review
Deutsche Bank sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 265,681 shares — an estimated $18.1M sold.
Deutsche Bank first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $32.6M in Q1 2018. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Deutsche Bank reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Deutsche Bank sold 265,681 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $18.1M.
- Deutsche Bank first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
- Deutsche Bank's Global Blood Therapeutics, Inc. position peaked at $32.6M in Q1 2018.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Deutsche Bank's 13F filing for Q4 2022, filed 13 Feb 2023.